Cancer Statistics, 2005

  title={Cancer Statistics, 2005},
  author={Ahmedin Jemal and Taylor Murray and Elizabeth E. Ward and Alicia Samuels and Ram C. Tiwari and Asma Ghafoor and Eric J. Feuer and Michael J. Thun},
  journal={CA: A Cancer Journal for Clinicians},
Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute and mortality data from the National Center for Health Statistics. Incidence and death rates are age‐standardized to the 2000 US standard million population. A total of 1,372,910 new cancer cases and 570,280 deaths are… 

Staging of prostate cancer.

  • Z. DotanJ. Ramon
  • Medicine
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer
  • 2007
Prostate cancer, with an incidence that is correlated to age, is the most common cancer tumor diagnosed among men older than 50 years, and an even higher incidence is found among patients older than

Annual productivity costs due to cervical cancer mortality in the United States.

  • R. Insinga
  • Medicine
    Women's health issues : official publication of the Jacobs Institute of Women's Health
  • 2006

Reduced lung cancer deaths attributable to decreased tobacco use in Massachusetts

Reductions in tobacco smoking are a major factor in the decrease in lung cancer mortality rates, largely because of the anti-smoking interventions in the past.

Cancer trends and incidence and mortality patterns in Turkey.

Cancer incidence growth rates for men exceed the cancer incidence growth rate for women, resulting mainly from lung cancer incidence which is much higher for men, leading to the widening of incidence gap between man and women.

Testis cancer.

The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States

The National Cancer Data Base (NCDB) is a nationwide oncology outcomes database that currently collects information on approximately 70% of all new invasive cancer diagnoses in the United States each

Therapeutic Targets in Colorectal Cancer

The rationale for targeted therapies and the identification of therapeutic targets is that the disease can be prevented prior to initiation and obstructed in its progression by blocking or inhibiting mechanisms that sustain progression and facilitate metastatic spread by being reversed.

Studies on screening and surveillance for colorectal cancer

The earlier stage detection of CRC improves the survival rate for CRC, and further improvement of survival can be expected from the introduction of population-based screening for CRC.



Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.

Cancer death rates for all cancer sites combined and for many common cancers have declined at the same time as the dissemination of guideline-based treatment into the community has increased, although this progress is not shared equally across all racial and ethnic populations.

Trends in Breast Cancer by Race and Ethnicity

Trends in incidence, mortality, and survival rates of female breast cancer in the United States by race and ethnicity are described and continued efforts are needed to increase the availability of high‐quality mammography and treatment to all segments of the population.

Impact of reporting delay and reporting error on cancer incidence rates and trends.

Investigating the impact of reporting delay and reporting error on incidence rates and trends for cancers of the female breast, colorectal, lung/bronchus, prostate, and melanoma found reporting-adjusted cancer incidence rates are valuable in precisely determining current cancer incidence levels and trends and in monitoring the timeliness of data collection.

A New Method of Predicting US and State‐Level Cancer Mortality Counts for the Current Calendar Year

The improved accuracy of the new method was particularly evident for prostate cancer, for which mortality rates changed dramatically in the late 1980s and early 1990s.

Cancer Disparities by Race/Ethnicity and Socioeconomic Status

Differences in cancer incidence, mortality, and survival in relation to race/ethnicity, and census data on poverty in the county or census tract of residence are highlighted.

Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study.

This study describes racial or ethnic patterns of cancer-specific survival and relative risks of cancer death for all cancers combined and for cancers of the colon and rectum, lung and bronchus, prostate, and female breast for the 6 major USracial or ethnic groups.

Survival of blacks and whites after a cancer diagnosis.

Only modest cancer-specific survival differences are evident for blacks and whites treated comparably for similar-stage cancer, suggesting differences in cancer biology between racial groups are unlikely to be responsible for a substantial portion of the survival discrepancy.

Cancer statistics for african americans

Evidence is now accumulating that the causes of increased cancer morbidity and mortality in African Americans are related more to poverty and lack of education and access to care than to any inherent racial characteristics.

Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival

The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR)

International Classification of Diseases for Oncology

Use ofImmunofluorescence in the Diagnosis of Virus Infections using audio-tape slide programme and slides and cassette by P. S. Gardner.